A Multicenter Study of Intramedullary Rodding in Osteogenesis Imperfecta
- PMID: 32984750
- PMCID: PMC7489747
- DOI: 10.2106/JBJS.OA.20.00031
A Multicenter Study of Intramedullary Rodding in Osteogenesis Imperfecta
Abstract
Background: Osteogenesis imperfecta (OI), a heritable connective tissue disorder with wide clinical variability, predisposes to recurrent fractures and bone deformity. Management requires a multidisciplinary approach in which intramedullary rodding plays an important role, especially for moderate and severe forms. We investigated the patterns of surgical procedures in OI in order to establish the benefits of rodding. The main hypothesis that guided this study was that rodded participants with moderate and severe OI would have lower fracture rates and better mobility.
Methods: With data from the Linked Clinical Research Centers, we analyzed rodding status in 558 individuals. Mobility and fracture data in OI Types III and IV were compared between rodded and non-rodded groups. Univariate regression analyses were used to test the association of mobility outcomes with various covariates pertinent to rodding.
Results: Of the individuals with OI, 42.1% had undergone rodding (10.7% of those with Type I, 66.4% with Type III, and 67.3% with Type IV). Rodding was performed more frequently and at a younger age in femora compared with tibiae. Expanding intramedullary rods were used more frequently in femora. In Type III, the rate of fractures per year was significantly lower (p ≤ 0.05) for rodded bones. In Type III, the mean scores on the Gillette Functional Assessment Questionnaire (GFAQ) and Brief Assessment of Motor Function (BAMF) were higher in the rodded group. However, Type-IV non-rodded subjects had higher mean scores in nearly all mobility outcomes. OI type, the use of expanding rods in tibiae, and anthropometric measurements were associated with mobility outcomes scores.
Conclusions: Current practice in 5 orthopaedic centers with extensive experience treating OI demonstrates that most individuals with moderate and severe types of OI undergo rodding procedures. Individuals with severe OI have improved mobility outcomes and lower fracture rates compared with their non-rodded peers, which suggests that early bilateral rodding benefits OI Type III. Our analysis showed a change in practice patterns in the final years of the study in the severe forms, with earlier and more simultaneous rodding procedures performed.
Level of evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
Copyright © 2020 The Authors. Published by The Journal of Bone and Joint Surgery, Incorporated. All rights reserved.
Conflict of interest statement
Disclosure: The study was supported by the BBDC (1U54AR068069-0), a part of the Rare Diseases Clinical Research Network (RDCRN) of the National Center for Advancing Translational Sciences (NCATS); the Clinical Translational Core of the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (BCM IDDRC) (1U54HD083092) from the Eunice Kennedy Shriver NICHD (National Institute of Child Health and Human Development); U.S. Department of Health and Human Services/National Institute on Disability, Independent Living, and Rehabilitation Research (HHS/NIDILRR) grant 90AR5022-01; and internal support from Shriners Hospitals for Children. The BBDC is funded through the Osteogenesis Imperfecta (OI) Foundation and the Office of Rare Diseases Research (ORDR) of the NCATS, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of Child Health and Human Development (NICHD), and the National Institute of Dental and Craniofacial Research (NIDCR). On the Disclosure of Potential Conflicts of Interest forms, which are provided with the online version of the article, one or more of the authors checked “yes” to indicate that the author had a relevant financial relationship in the biomedical arena outside the submitted work (http://links.lww.com/JBJSOA/A198).
Figures
Similar articles
-
Re-alignment and intramedullary rodding of the humerus and forearm in children with osteogenesis imperfecta: revision rate and effect on fracture rate.J Child Orthop. 2017 Jun 1;11(3):185-190. doi: 10.1302/1863-2548.11.160214. J Child Orthop. 2017. PMID: 28828061 Free PMC article.
-
Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year.J Child Orthop. 2011 Jun;5(3):217-24. doi: 10.1007/s11832-011-0341-7. Epub 2011 May 8. J Child Orthop. 2011. PMID: 22654983 Free PMC article.
-
Results of Rodding and Impact on Ambulation and Refracture in Osteogenesis Imperfecta: Study of 21 Children.Indian J Orthop. 2019 Jul-Aug;53(4):554-559. doi: 10.4103/ortho.IJOrtho_202_18. Indian J Orthop. 2019. PMID: 31303672 Free PMC article.
-
Orthopaedic treatment of osteogenesis imperfecta.Ann N Y Acad Sci. 1988;543:157-66. doi: 10.1111/j.1749-6632.1988.tb55328.x. Ann N Y Acad Sci. 1988. PMID: 3063161 Review.
-
Recent progress in diagnosis and treatment of osteogenesis imperfecta.Acta Paediatr Jpn. 1997 Aug;39(4):521-7. doi: 10.1111/j.1442-200x.1997.tb03631.x. Acta Paediatr Jpn. 1997. PMID: 9316304 Review.
Cited by
-
A Retrospective Study of the Presentation, Diagnosis, Management, and Outcomes of 27 Patients with Osteogenesis Imperfecta at a Single Center in Türkiye.Med Sci Monit. 2024 May 29;30:e944364. doi: 10.12659/MSM.944364. Med Sci Monit. 2024. PMID: 38807347 Free PMC article.
-
"Osteogenesis Imperfecta Patients Wish Orthopedic Surgeons Had Better Strategies to Help with…"-Results of a Patient and Parent-Oriented Survey.Children (Basel). 2023 Aug 4;10(8):1345. doi: 10.3390/children10081345. Children (Basel). 2023. PMID: 37628344 Free PMC article.
-
The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review.Orphanet J Rare Dis. 2023 Feb 22;18(1):34. doi: 10.1186/s13023-023-02627-3. Orphanet J Rare Dis. 2023. PMID: 36814274 Free PMC article. Review.
-
A multicenter study to evaluate pain characteristics in osteogenesis imperfecta.Am J Med Genet A. 2023 Jan;191(1):160-172. doi: 10.1002/ajmg.a.63009. Epub 2022 Oct 22. Am J Med Genet A. 2023. PMID: 36271817 Free PMC article.
-
Prognostic factors for mobility in children with osteogenesis imperfecta.Medicine (Baltimore). 2022 Sep 9;101(36):e30521. doi: 10.1097/MD.0000000000030521. Medicine (Baltimore). 2022. PMID: 36086743 Free PMC article.
References
-
- Patel RM, Nagamani SC, Cuthbertson D, Campeau PM, Krischer JP, Shapiro JR, Steiner RD, Smith PA, Bober MB, Byers PH, Pepin M, Durigova M, Glorieux FH, Rauch F, Lee BH, Hart T, Sutton VR. A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers. Clin Genet. 2015. February;87(2):133-40. Epub 2014 May 30. - PMC - PubMed
-
- Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000. September;15(9):1650-8. - PubMed
-
- Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 2002. January;17(1):30-8. - PubMed
-
- Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, Roughley PJ, Glorieux FH. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone. 2002. July;31(1):12-8. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials